US HR1274 | 2021-2022 | 117th Congress

Status

Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on July 26 2022 - 25% progression, died in chamber
Action: 2022-09-29 - Placed on the House Calendar, Calendar No. 133.
Text: Latest bill text (Introduced) [PDF]

Summary

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

Sponsors


History

DateChamberAction
2022-09-29HousePlaced on the House Calendar, Calendar No. 133.
2022-09-29HouseReported by the Committee on Energy and Commerce. H. Rept. 117-527.
2022-09-21HouseOrdered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.
2022-09-21HouseCommittee Consideration and Mark-up Session Held.
2022-09-21HouseSubcommittee on Health Discharged.
2022-07-27HouseReferred to the Subcommittee on Health.
2022-07-26HouseReferred to the House Committee on Energy and Commerce.
2022-07-26HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback